Recombinant yellow fever vaccine virus 17D expressing simian immunodeficiency virus SIVmac239 gag induces SIV-specific CD8+ T-cell responses in rhesus macaques

J Virol. 2010 Apr;84(7):3699-706. doi: 10.1128/JVI.02255-09. Epub 2010 Jan 20.

Abstract

Here we describe a novel vaccine vector for expressing human immunodeficiency virus (HIV) antigens. We show that recombinant attenuated yellow fever vaccine virus 17D expressing simian immunodeficiency virus SIVmac239 Gag sequences can be used as a vector to generate SIV-specific CD8(+) T-cell responses in the rhesus macaque. Priming with recombinant BCG expressing SIV antigens increased the frequency of these SIV-specific CD8(+) T-cell responses after recombinant YF17D boosting. These recombinant YF17D-induced SIV-specific CD8(+) T cells secreted several cytokines, were largely effector memory T cells, and suppressed viral replication in CD4(+) T cells.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • CD4-Positive T-Lymphocytes / virology
  • CD8-Positive T-Lymphocytes / immunology*
  • Gene Products, gag / genetics
  • Gene Products, gag / immunology
  • Macaca mulatta
  • Peptide Fragments / immunology
  • SAIDS Vaccines / immunology*
  • Simian Immunodeficiency Virus / immunology*
  • Vaccines, Synthetic / immunology
  • Yellow Fever Vaccine / immunology
  • Yellow fever virus / genetics*

Substances

  • Gene Products, gag
  • Peptide Fragments
  • SAIDS Vaccines
  • Vaccines, Synthetic
  • Yellow Fever Vaccine